Prostate cancer: advances in treatment. Feature in Clarín

Multiple therapeutic options allow a better approach to the disease. Regular check-ups are key.

Prostate cancer is the most common visceral tumor in men and, until the end of the 20th century, was the second cause of death in men over 50, after lung cancer. According to the National Cancer Institute, more than 11,000 cases of prostate tumors are detected each year in Argentina.

It is essential that every man over 50 see a urologist. In cases where the patient has a first-degree relative with a history of prostate cancer, the first visit should be at 45. The foundation of early detection is the individual assessment of the risk of developing prostate cancer. Age, race, body type, and personal and family history, together with the physical exam, will frame the rational use of the prostate-specific antigen, a molecule circulating in the blood that is specific to the prostate gland (PSA). It should be noted that not all PSA elevations are caused by cancer, so the specialist's interpretation is crucial.

Read the full feature in Clarín.